(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||
Cash from operating activities | -231K | -4.42M | -1.69%1.84M | -78.34%1.87M | 8.63M |
Net profit before non-cash adjustment | --4.33M | ---152K | 15.92%8.72M | 13.92%7.52M | --6.6M |
Total adjustment of non-cash items | --260K | --182K | 9.78%1.6M | 151.03%1.46M | --581.33K |
-Depreciation and amortization | --393K | --350K | 14.43%1.36M | -12.24%1.19M | --1.36M |
-Reversal of impairment losses recognized in profit and loss | --16K | ---13K | -108.70%-37.23K | 107.69%427.97K | --206.07K |
-Share of associates | ---184K | --34K | 104.62%10.9K | -1,536.26%-235.83K | ---14.41K |
-Disposal profit | --0 | ---216K | -301.35%-13.04K | 40.35%-3.25K | ---5.45K |
-Net exchange gains and losses | --3K | --9K | -65.36%-1.86K | -294.97%-1.12K | --576 |
-Pension and employee benefit expenses | ---9K | --6K | 2,706.09%155.32K | --5.54K | --0 |
-Other non-cash items | --41K | --12K | 67.73%123.38K | 107.63%73.56K | ---964.32K |
Changes in working capital | ---4.82M | ---4.45M | -19.29%-8.48M | -592.00%-7.11M | --1.45M |
-Change in receivables | ---2.29M | ---1.49M | 62.22%-4.75M | -1,064.01%-12.57M | --1.3M |
-Change in inventory | ---9K | ---9K | --0 | --0 | --0 |
-Change in payables | ---6.02M | --2.14M | -177.24%-4.14M | 1,832.76%5.36M | --277.12K |
-Provision for loans, leases and other losses | --68K | ---87K | 507.48%191.47K | -70.59%-46.99K | ---27.55K |
-Changes in other current assets | --3.43M | ---5M | 41.17%209.19K | 237.44%148.18K | ---107.81K |
Dividends paid (cash flow from operating activities) | |||||
Dividends received (cash flow from operating activities) | |||||
Interest paid (cash flow from operating activities) | -89K | -76K | -44.34%-250.08K | 18.29%-173.25K | -212.03K |
Interest received (cash flow from operating activities) | 26K | 41K | -9.65%90.07K | -30.92%99.69K | 144.31K |
Tax refund paid | -450K | -526K | -33.55%-1.66M | -16.80%-1.24M | -1.06M |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | ---744K | ---4.98M | -96.29%20.58K | -92.60%554.99K | --7.5M |
Investing cash flow | |||||
Net PPE purchase and sale | ---197K | ---131K | -29.73%-523.5K | 51.69%-403.52K | ---835.22K |
Net business purchase and sale | ---150K | ---30K | -156.33%-405.03K | 2,760.95%719.07K | --25.13K |
Net investment product transactions | ---- | ---- | -90.73%41.97K | 194.87%452.57K | ---477.05K |
Advance cash and loans provided to other parties | ---- | ---- | ---777.9K | --0 | --0 |
Net changes in other investments | --626K | --888K | ---- | ---- | ---- |
Investing cash flow | --279K | --727K | -316.69%-1.66M | 159.68%768.12K | ---1.29M |
Financing cash flow | |||||
Net issuance payments of debt | ---243K | ---305K | -93.35%149.09K | 3,514.79%2.24M | ---65.63K |
Net common stock issuance | --0 | --58.87M | --100 | --0 | --0 |
Increase or decrease of lease financing | ---203K | ---163K | 8.15%-693.05K | -13.46%-754.54K | ---665.04K |
Cash dividends paid | ---- | ---- | ---- | ---- | ---1M |
Net other fund-raising expenses | ---15K | ---16K | 270.22%88.02K | -42.14%-51.71K | ---36.38K |
Financing cash flow | ---2.09M | --58.38M | -131.77%-455.85K | 181.20%1.43M | ---1.77M |
Net cash flow | |||||
Beginning cash position | --65.75M | --11.62M | 38.58%9.91M | 164.31%7.15M | --2.71M |
Current changes in cash | ---2.55M | --54.13M | -176.13%-2.1M | -37.97%2.76M | --4.45M |
Effect of exchange rate changes | ---- | ---- | 65.36%1.86K | 294.97%1.12K | ---576 |
End cash Position | --63.2M | --65.75M | -21.17%7.81M | 38.58%9.91M | --7.15M |
Free cash flow | ---941K | ---5.33M | -455.70%-538.77K | -97.72%151.47K | --6.65M |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data